DEUTSCHE BANK AG\ - PHARMATHENE INC ownership

PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 40 filers reported holding PHARMATHENE INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of PHARMATHENE INC
ValueSharesWeighting
Q1 2017$67,000
-97.7%
84,022
-90.4%
0.00%
-100.0%
Q4 2016$2,855,000
+178.3%
879,067
+148.2%
0.00%
+100.0%
Q3 2016$1,026,000
+210.9%
354,160
+160.6%
0.00%
Q2 2016$330,000
+6500.0%
135,910
+4147.2%
0.00%
Q4 2014$5,000
+400.0%
3,200
+433.3%
0.00%
Q1 2014$1,000
-99.6%
600
-99.6%
0.00%
Q3 2013$280,000133,6000.00%
Other shareholders
PHARMATHENE INC shareholders Q4 2013
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 520,000$422,0000.44%
FIRST QUADRANT LLC/CA 1,655,539$1,343,0000.03%
OXFORD ASSET MANAGEMENT LLP 1,118,005$907,0000.02%
CIGNA INVESTMENTS INC /NEW 303,239$246,0000.02%
Burt Wealth Advisors 17,870$15,0000.01%
Sullivan, Bruyette, Speros & Blaney, LLC 126,346$103,0000.01%
ClariVest Asset Management LLC 322,970$262,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 594,444$482,0000.01%
Renaissance Technologies 4,790,931$3,888,0000.01%
Mraz, Amerine & Associates, Inc. 20,000$15,0000.01%
View complete list of PHARMATHENE INC shareholders